2021年2月8日 · He added that these hybrid vials also have a very low risk of delamination, with a sub-visible particle rate approaching zero. In June, SiO2 was also awarded a grant by the US Government worth $143 million, to enable them to manufacture their hybrid vials for use in COVID-19 vaccines.